Prognostic value of metabolic tumor burden in lung cancer.
about
Positron Emission Tomography (PET) in OncologyEfficacy of third-line pemetrexed monotherapy versus pemetrexed combination with bevacizumab in patients with advanced EGFR mutation-positive lung adenocarcinomaA new PET/CT volumetric prognostic index for non-small cell lung cancerClinically determined type of 18F-fluoro-2-deoxyglucose uptake as an alternative prognostic marker in resectable pancreatic cancer.Microscopic Invasions, Prognoses, and Recurrence Patterns of Stage I Adenocarcinomas Manifesting as Part-Solid Ground-Glass Nodules: Comparison With Adenocarcinomas Appearing as Solid Nodules After Matching Their Solid Parts' Size.Metabolic tumor volume predicts overall survival and local control in patients with stage III non-small cell lung cancer treated in ACRIN 6668/RTOG 0235.
P2860
Prognostic value of metabolic tumor burden in lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prognostic value of metabolic tumor burden in lung cancer.
@en
Prognostic value of metabolic tumor burden in lung cancer.
@nl
type
label
Prognostic value of metabolic tumor burden in lung cancer.
@en
Prognostic value of metabolic tumor burden in lung cancer.
@nl
prefLabel
Prognostic value of metabolic tumor burden in lung cancer.
@en
Prognostic value of metabolic tumor burden in lung cancer.
@nl
P2860
P1476
Prognostic value of metabolic tumor burden in lung cancer.
@en
P2093
Piotr Obara
Yonglin Pu
P2860
P304
P356
10.3978/J.ISSN.1000-9604.2013.11.10
P577
2013-12-01T00:00:00Z